SEP Acquisition (SEPA) Competitors

$10.25
-0.76 (-6.90%)
(As of 05/15/2024 ET)

SEPA vs. MAQC, NVNO, SWSS, PDEX, STIM, SRTS, MGRM, AMIX, HSAQ, and ICCM

Should you be buying SEP Acquisition stock or one of its competitors? The main competitors of SEP Acquisition include Maquia Capital Acquisition (MAQC), enVVeno Medical (NVNO), Clean Energy Special Situations (SWSS), Pro-Dex (PDEX), Neuronetics (STIM), Sensus Healthcare (SRTS), Monogram Orthopaedics (MGRM), Autonomix Medical (AMIX), Health Sciences Acquisitions Co. 2 (HSAQ), and IceCure Medical (ICCM).

SEP Acquisition vs.

Maquia Capital Acquisition (NASDAQ:MAQC) and SEP Acquisition (NASDAQ:SEPA) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation, profitability and community ranking.

12.4% of Maquia Capital Acquisition shares are held by institutional investors. Comparatively, 3.7% of SEP Acquisition shares are held by institutional investors. 78.4% of Maquia Capital Acquisition shares are held by insiders. Comparatively, 20.0% of SEP Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Maquia Capital Acquisition has a beta of -0.01, suggesting that its stock price is 101% less volatile than the S&P 500. Comparatively, SEP Acquisition has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maquia Capital Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
SEP Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Maquia Capital Acquisition and SEP Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Maquia Capital AcquisitionN/AN/A
SEP AcquisitionN/AN/A

In the previous week, SEP Acquisition had 2 more articles in the media than Maquia Capital Acquisition. MarketBeat recorded 3 mentions for SEP Acquisition and 1 mentions for Maquia Capital Acquisition. SEP Acquisition's average media sentiment score of 1.87 beat Maquia Capital Acquisition's score of 0.94 indicating that Maquia Capital Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Maquia Capital Acquisition Very Positive
SEP Acquisition Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maquia Capital AcquisitionN/AN/A-$960KN/AN/A
SEP AcquisitionN/AN/A-$2.36MN/AN/A

Company Net Margins Return on Equity Return on Assets
Maquia Capital AcquisitionN/A N/A -5.09%
SEP Acquisition N/A N/A -16.47%

Summary

Maquia Capital Acquisition beats SEP Acquisition on 5 of the 7 factors compared between the two stocks.

Get SEP Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for SEPA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEPA vs. The Competition

MetricSEP AcquisitionSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$59.55M$3.91B$5.10B$7.99B
Dividend YieldN/A2.01%36.92%3.93%
P/E RatioN/A16.90186.2018.76
Price / SalesN/A72.062,297.5979.43
Price / CashN/A46.9335.5831.18
Price / Book-16.274.675.464.47
Net Income-$2.36M$4.48M$105.01M$217.31M
7 Day Performance-5.79%1.87%1.42%1.57%
1 Month Performance3.33%3.19%3.72%5.04%
1 Year Performance2.71%18.87%7.93%12.01%

SEP Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MAQC
Maquia Capital Acquisition
0 of 5 stars
$11.06
flat
N/A+0.9%$68.35MN/A0.004
NVNO
enVVeno Medical
0.239 of 5 stars
$5.10
+0.8%
N/A+21.7%$67.93MN/A-2.6619
SWSS
Clean Energy Special Situations
0 of 5 stars
$10.54
-1.5%
N/A+1.8%$73.89MN/A0.002,021Gap Up
PDEX
Pro-Dex
0 of 5 stars
$18.70
+4.5%
N/A+24.0%$63.95M$46.09M32.24145Gap Up
STIM
Neuronetics
2.4266 of 5 stars
$2.55
-1.9%
$8.00
+213.7%
-13.8%$76.45M$71.35M-2.38203Analyst Upgrade
News Coverage
SRTS
Sensus Healthcare
4.3183 of 5 stars
$3.83
+1.3%
$8.00
+108.9%
+112.5%$62.77M$24.41M127.7135Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
Gap Up
MGRM
Monogram Orthopaedics
0.7527 of 5 stars
$1.90
-3.1%
N/AN/A$60.11M$364,999.00-2.4128Gap Up
AMIX
Autonomix Medical
0 of 5 stars
$3.06
+8.9%
N/AN/A$57.50MN/A0.001Positive News
HSAQ
Health Sciences Acquisitions Co. 2
0 of 5 stars
$4.98
-5.0%
N/A-72.4%$55.84MN/A0.004
ICCM
IceCure Medical
2.6059 of 5 stars
$1.17
-3.3%
$2.95
+152.1%
-3.2%$53.38M$3.23M-3.5571Short Interest ↓

Related Companies and Tools

This page (NASDAQ:SEPA) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners